Clean Science and Technology ki subsidiary, Clean Fino-Chem ne HALS products ke trials successful kar liye hain. Geneus Chem AG ke saath milkar banaye gaye ye products ab market mein aane ke liye taiyaar hain.
Trial hua clear, ab next step kya hai?
Clean Science and Technology ki wholly-owned subsidiary, Clean Fino-Chem Limited (CFCL) ne finally Hindered Amine Light Stabilizers (HALS) ke trials complete kar liye hain. Geneus Chem AG ke saath collaboration mein bane ye products saare quality standards aur regulatory tests mein khare utre hain.
Investors ke liye kyun important hai?
HALS ka use polymers ko UV light se bachane ke liye hota hai, jo specialty chemicals segment mein kaafi demand mein rehta hai. Ab tak Clean Science apne core chemicals ke liye jaana jata tha, lekin ye move unke portfolio diversification ki taraf ek bada kadam hai. Trial successful hone ka matlab hai ki technology ab solid hai aur risk kam ho gaya hai.
Timeline par rakhein nazar
Company ne commercial production ke liye FY 2026-27 ki second half (H2) ka target rakha hai. Agle 18 se 24 mahine tak company ka focus ab plant setup aur customer supply chain banane par hoga.
Kya risks hain?
Halanki news positive hai, par investors ko yaad rakhna chahiye ki commercial revenue abhi door hai. Plant commissioning mein delay ya market competition ek factor ho sakta hai. Ab aapko sirf ye track karna hai ki company kitni jaldi production infrastructure ready karti hai aur kaunse major clients se contract sign karti hai.